Healthcare of Ontario Pension Plan Trust Fund Increases Position in Synopsys, Inc. $SNPS

Healthcare of Ontario Pension Plan Trust Fund grew its stake in Synopsys, Inc. (NASDAQ:SNPS) by 6.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,227 shares of the semiconductor company’s stock after acquiring an additional 3,713 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Synopsys were worth $30,169,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in SNPS. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Synopsys in the 4th quarter valued at $28,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys in the 4th quarter valued at $28,000. Atlas Capital Advisors Inc. purchased a new position in shares of Synopsys in the 4th quarter valued at $32,000. Oakworth Capital Inc. increased its holdings in shares of Synopsys by 3,700.0% in the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock valued at $36,000 after acquiring an additional 74 shares during the period. Finally, Greenline Wealth Management LLC purchased a new position in shares of Synopsys in the 4th quarter valued at $37,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by company insiders.

Synopsys Stock Up 0.1%

Shares of SNPS stock opened at $454.38 on Tuesday. Synopsys, Inc. has a 1-year low of $376.18 and a 1-year high of $651.73. The stock’s fifty day moving average price is $474.73 and its 200 day moving average price is $461.19. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The company has a market cap of $87.00 billion, a price-to-earnings ratio of 105.18, a price-to-earnings-growth ratio of 2.67 and a beta of 1.22.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the previous year, the business earned $3.67 EPS. The firm’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

SNPS has been the topic of a number of analyst reports. Berenberg Bank set a $633.00 price target on Synopsys in a report on Wednesday, May 27th. Robert W. Baird set a $558.00 price target on Synopsys in a report on Thursday, May 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the company a “buy” rating in a report on Wednesday, February 25th. Finally, Morgan Stanley boosted their target price on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $563.81.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.